The effects of interleukin (IL)-10, a potent antiinflammatory cytokine, on human monocyte functions against two medically important pathogens, Candida albicans and Staphylococcus aureus, were studied. Incubation with 20-100 ng/mL IL-10 for 2-3 days decreased the fungicidal activity of monocytes against serum-opsonized C. albicans blastoconidia ( ), P ≤ .04 reduced their capacity to damage unopsonized hyphae ( ), and suppressed superoxide P ≤ .006 anion production in response to phorbol myristate acetate ( ) and N-FMLP ( P ϭ .019 P ϭ ) but not to serum-opsonized blastoconidia. Paradoxically, IL-10 enhanced phagocytic .04 activity of monocytes against serum-opsonized blastoconidia (
been also shown to suppress nitric oxide production and candidacidal activity of murine macrophages [23] and generally is considered a macrophage deactivator [14] .
Because of its multiple suppressive activities on immune cells, IL-10 has the potential to be used as an antiinflammatory agent in septic shock [24] and in chronic inflammatory diseases [24] and as a specific immunosuppressive agent against rejection of transplanted organs [25] . As an application of these properties, clinical trials are currently being conducted for investigation of IL-10 in a number of diseases, including psoriatic arthritis, human immunodeficiency virus infection, and inflammatory bowel disease. However, administration of IL-10 to mice adversely affected host defenses during pneumonia due to Klebsiella pneumoniae [26] or Streptococcus pneumoniae [27] , disseminated infection by C. albicans [28] , and mycobacterial infections [29, 30] . To our knowledge, no study has examined the effects of IL-10 on human phagocyte effector function against S. aureus or C. albicans. We therefore investigated the effects of human IL-10 on selected antimicrobial activities of human monocytes (MNC) against these two important pathogens.
Materials and Methods
Preparation of MNC. Buffy coats were prepared from anticoagulated venous blood of healthy adult volunteers at the Transfusion Medicine Department of Hippokration Hospital, Thessaloniki, Greece. Mononuclear leukocytes were separated by centrifugation of buffy coats over ficoll (Lymphocyte Separation Medium; Life Technologies Gibco BRL, Paisley, UK). They were washed twice with Hanks' buffered salt solution (HBSS) free of Ca 2ϩ and Mg 2ϩ and resuspended in complete medium (CM) con-sisting of RPMI 1640, 25% pooled normal human serum (Transfusion Medicine Department, Hippokration Hospital), 100 units/ mL penicillin, and 100 mg/mL streptomycin. They were counted by trypan blue staining on a hemocytometer, and the percentage of MNC was estimated by May-Grü nwald-Giemsa staining. Mononuclear leukocytes were 195%, and ∼25%-45% of them were MNC.
Organisms. The isolates of S. aureus and C. albicans 86-21 used in this study have been well characterized and extensively used in previous studies [31, 32] . They were preserved in skim milk aliquots at Ϫ35ЊC. Preparative cultures of C. albicans were grown on Sabouraud dextrose agar (SDA) plates, and of S. aureus were grown on Mueller-Hinton agar plates at 37ЊC for 18-24 h. Blastoconidia of C. albicans were harvested from the SDA plate, inoculated into Sabouraud dextrose broth, and incubated at 37ЊC for 18 h in a shaking water bath. Blastoconidia were washed with HBSS and resuspended in HBSS at a final concentration of 10 7 colony-forming units (cfu) per milliliter. Similarly, individual S. aureus colonies were inoculated and grown in trypticase-soy broth for 2.5 h on a shaker at 37ЊC to obtain log-phase growth, washed with HBSS, and adjusted to a final concentration of cfu/ 7 2 ϫ 10 mL (bactericidal assay) or cfu/mL (bacterial phagocy-8 2.5 ϫ 10 tosis) by optical density and cfu counts. For brevity, the term hyphae is used to define pseudohyphae of C. albicans.
Reagents and pretreatment of effector cells. Human IL-10 with a specific activity of 1-2 ϫ 10 7 units/mg was a gift of DNAX (Palo Alto, CA). IL-10 was diluted in HBSS without Ca 2ϩ and Mg 2ϩ and was stored frozen at Ϫ35ЊC. Rat-mouse hybridoma cell line JES3-19F1.1.1 (producing antibody reactive with human IL-10) was obtained from American Type Culture Collection (Rockville, MD). The concentrations of IL-10 used to treat MNC were in the range that can be achieved during certain infectious processes or pharmacologically [24, 33, 34] . Anti-IL-10-containing supernatant of 1-week cultured hybridoma cell line in CM containing 10% fetal calf serum (Life Technologies; CM-FCS) instead of 25% human serum was centrifuged, filtered, and frozen at Ϫ35ЊC. In preliminary studies, IL-10 did not exert any direct effect on growth of C. albicans blastoconidia, germination, or growth of hyphae nor was there any effect on growth of S. aureus.
Briefly, we detached MNC from flasks in which they had been incubated with IL-10; cells were washed, resuspended in HBSS without Ca 2ϩ and Mg 2ϩ , and transferred to tubes in which the assays were performed. Two hundred microliters of a suspension of MNC ( /mL) in CM were placed in 12-well plates con- 6 5 ϫ 10 taining 18-mm sterile round glass coverslips (Costar, Cambridge, MA) for the fungal phagocytosis assay or in 12-well plates without coverslips for the superoxide anion (O 2Ϫ ) assay. Both plates were incubated at 37ЊC with 5% CO 2 for 45 min. The wells were then washed twice with warm HBSS not containing Ca 2ϩ and Mg 2ϩ . Fresh CM was added to the wells, and the glass-or plastic-adherent MNC were further incubated in 1 mL of CM at 37ЊC with 5% CO 2 with or without IL-10 for 2-3 days.
In addition, 1-MNC were cultured in each of 25-cm 2 7 2 ϫ 10 tissue culture flasks (Costar) with 10 mL of CM-FCS to assess bacterial phagocytosis, bactericidal activity, killing of blastoconidia (hereafter called conidiocidal activity), and hyphal damage. Flasks were placed at 37ЊC with 5% CO 2 for 2 h. They were then washed twice with warm HBSS not containing Ca 2ϩ and Mg 2ϩ . Fresh CM-FCS was added to the flasks, and the plastic-adherent MNC were further incubated in 10 mL of CM-FCS at 37ЊC with 5% CO 2 with or without IL-10 for 2-3 days. Adherent MNC were then detached from the bottom by scraping, washed twice, and resuspended in HBSS without Ca 2ϩ and Mg 2ϩ in order to be used in the assays. Fungicidal assays. For the conidiocidal assay, a standard cfu assay was used. MNC that had been incubated with CM-FCS only or with IL-10-containing CM-FCS in flasks were transferred to tubes and mixed with 10 6 blastoconidia at an effector-to-target cell (E:T) ratio of 1:1 and 10% pooled human serum in 1 mL of HBSS [31] . Control tubes containing blastoconidia, human serum, and HBSS but not MNC were included in each experiment. The mixture was rotated at 37ЊC for 2 h. After complete lysis of MNC with sterile H 2 O at the end of incubation, dilutions were made, and samples were plated in duplicate on SDA plates and incubated at 37ЊC for 18 h. Colonies were counted, and conidiocidal activity was calculated using the formula: % Ϫ , killing ϭ (1 X/C ) ϫ 100 where X is the number of cfu with MNC at 2 h and C is the number of cfu without MNC at 2 h.
To assess hyphal damage, the colorimetric MTT assay [35] was adapted for C. albicans hyphae [32] . Briefly, a suspension of blastoconidia/mL in RPMI 1640 was prepared, and 1-mL 5 2.5 ϫ 10 aliquots were plated in 24-well plates (Costar). The plates were incubated at 37ЊC for 4 h, by which time 195% of blastoconidia had germinated to hyphae. The supernatants were aspirated, and MNC that had been incubated with CM-FCS only or with IL-10-containing CM-FCS in flasks for 2-3 days were added to the wells at E:T ratios of 2:1 and 5:1. After 2 h at 37ЊC and 5% CO 2 , supernatants were aspirated, MNC were lysed by adding 300 mL of 0.5% sodium deoxycholate, and hyphae were washed three times with sterile water. Subsequently, 1 mL of RPMI 1640 containing 0.5 mg/mL MTT was added to each well, and the plates were further incubated at 37ЊC and 5% CO 2 for 3 h. The wells were then aspirated dry, 200 mL of isopropanol were used to extract the dye in each well, volumes of 150 mL were transferred into a 96-well plate (Costar), and the color (optical density, OD) was measured on a microplate reader (PerkinElmer, Wilfon, CT) at 540 nm. A well containing only isopropanol was used as a blank. Control wells containing hyphae and buffer only were included. Antifungal activity (hyphal damage) was calculated using the formula: % hyphal Ϫ , damage ϭ (1 X/C ) ϫ 100 where X is the OD of test wells at 2 h and C is the OD of control wells containing hyphae only. Each condition was tested in duplicate or quadruplicate, and the results were averaged.
Bactericidal assay. A standard cfu assay was used for assessing bactericidal activity [31] . Monocytes were coincubated with cfu of S. aureus at an E:T ratio of 1:1 in 1 mL of HBSS 6 2.5 ϫ 10 containing 10% normal pooled human serum. Control tubes containing bacteria, human serum, and HBSS but not MNC were included in each experiment. Preparations were rotated at 37ЊC for 30 min. Monocytes were lysed with sterile H 2 O, and serial dilutions were plated on Mueller-Hinton medium and incubated at 37ЊC for 18 h. Colonies were counted, and bactericidal activity was assessed by calculating the percent killing of bacteria compared with the control. The following formula was used: % Ϫ killing ϭ (1 , where X is the number of cfu with monocytes at 30 X/C ) ϫ 100 min and C is the number of cfu in the control at 30 min.
Phagocytosis of blastoconidia. After incubation of MNC with IL-10 in wells, supernatants were removed and 1 mL of CM con- Figure 1 . Effect of interleukin (IL)-10 on conidiocidal activity of monocytes (MNC) against blastoconidia of C. albicans in presence of human serum. Data are from 9 (0 ng/mL), 4 (0.2, 2, and mean ‫ע‬ SE 100 ng/mL), and 7 (20 ng/mL) experiments. MNC were pretreated with concentrations of IL-10 shown at horizontal axis for 2-3 days at 37ЊC and then added to tubes containing 10 6 blastoconidia at effector-totarget cell ratio of 1:1 and 10% pooled human serum and incubated at 37ЊC for 2 h. Differences of IL-10-treated MNC from mediumpretreated MNC are significant (* , † ). P ϭ .02 P ϭ .04 taining 10 6 C. albicans blastoconidia was added to each well. Following a 15-min incubation at 37ЊC with 5% CO 2 for phagocytosis, coverslips were washed vigorously three times with warm HBSS not containing Ca 2ϩ and Mg 2ϩ to remove the extracellular and attached blastoconidia, and the cells were fixed and stained with May-Grü nwald-Giemsa. Phagocytic activity of MNC was assessed by light microscopy in duplicate coverslips. The percent phagocytosis was determined as the percentage of MNC that had one or more blastoconidia phagocytosed after counting 100 of them. The phagocytic index was the average number of blastoconidia that had been phagocytosed by each MNC [31] . Blastoconidia that were !50% in contact with the membrane of MNC or appeared to be intracellular with no clear surrounding halo were not counted as phagocytosed.
Phagocytosis of bacteria. Phagocytosis of S. aureus by MNC was assessed by direct microscopy as previously described [31] .
Briefly, 10 8 serum-preopsonized S. aureus bacteria were mixed with 10 6 MNC that had been previously incubated with CM-FCS alone or with CM-FCS containing various concentrations of IL-10 in 1 mL of HBSS, at a final E:T ratio of 1:100. Preparations were rotated at 37ЊC. Samples were obtained after 10 min and immediately mixed with cold N-ethylmaleimide (0.1 mM; Sigma, St. Louis) to inhibit additional phagocytosis. They were then incubated with lysostaphin (20 U/mL; Sigma) at 37ЊC for an additional 10 min to lyse the nonphagocytosed, extracellular bacteria. Preparations were cytocentrifuged and stained with May-Grü nwaldGiemsa. The percent phagocytosis was calculated as the proportion of MNC containing one or more bacteria among 100 MNC. A weighted phagocytic index was calculated by multiplying the number of MNC having either 1-10, 11-20, 21-30, 31-40 or 140 ingested organisms by either 1, 2, 3, 4, or 5, respectively, and dividing the total score by the number of MNC examined (usually 100).
Superoxide anion production assay. Superoxide anion (O 2 Ϫ ) production in response to soluble and particulate stimuli was assessed spectrophotometrically in a cytochrome c reduction assay [36] . One million MNC that had been incubated with CM only or with IL-10-containing CM in wells were mixed with 50 mM cytochrome c (Sigma) in 1 mL of HBSS. The mixture was incubated at 37ЊC for 15 min with one of the following stimuli: 100 ng/mL phorbol myristate acetate (PMA), 500 nM N-FMLP (both from Sigma), or serum-opsonized blastoconidia of C. albicans at an E: T ratio of 1:2. Control tubes not containing MNC but having the remaining constituents were included. After this incubation, O 2Ϫ production was assessed as the difference in absorption from the control at 550 nm that was measured on a photometer (Micro Elisa Strip Reader 301; Bio-Tek, Winooski VT). Superoxide anion produced by 10 6 MNC was then calculated using the millimolar extinction coefficient for reduced cytochrome c.
Statistics. Data were expressed as mean ‫ע‬ SE. Differences between values at individual IL-10 concentrations and baseline values were assessed by use of the paired Student's t test or analysis of variance with Dunnett's correction for multiple comparisons. The difference in bactericidal activity between IL-10 treatment and baseline value was evaluated by the Wilcoxon signed rank test with the Bonferroni correction. All P values were two-sided, and P ! was considered to be significant. .05
Results
Effect of IL-10 on fungicidal activity of MNC against blastoconidia of C. albicans. After incubation of MNC and blastoconidia at an E:T ratio of 1:1 in the presence of 10% pooled human serum for 2 h, concentrations of 20-100 ng/mL IL-10 were found to significantly decrease the percent killing of blastoconidia by MNC. For example, at 100 ng/mL IL-10, the percent killing was compared with 27.6% ‫ע‬ 11.1% 53.6% ‫ע‬ for controls, ; figure 1 ). At 20 ng/mL, IL-10 also 4.3% P ϭ .04 suppressed conidiocidal activity from baseline to 42.5% ‫ע‬ ( ; figure 1) . In two duplicate experiments in which 4.8% P ϭ .02 anti-IL-10-containing supernatant was used in combination with 20 ng/mL IL-10, the suppressive activity of IL-10 was partially inhibited (table 1) .
Effect of IL-10 on MNC-induced damage of C. albicans hy- NOTE. Anti-IL-10 was added to MNC cultures with anti-IL-10-containing supernatant of rat-mouse hybridoma cell line diluted 1/2 in complete medium (see Materials and Methods). Fetal calf serum (carrier of anti-IL-10 antibody) had no effect on MNC-induced % killing of blastoconidia. IL-10 (20 ng/mL) was added at same time as anti-IL-10 to appropriate cultures, and incubation lasted for 2 days. Results are for 2 duplicate experiments. mean ‫ע‬ SE phae. The effect of IL-10 on antifungal activity of MNC against Candida hyphae (hyphal damage) was then evaluated by use of a 2-h MTT assay and E:T ratios of 2:1 and 5:1 (figure 2). After incubation of MNC with 20 or 100 ng/mL IL-10 at 37ЊC for 2-3 days, the capacity of MNC to damage unopsonized hyphae was significantly decreased. For example, at an E: T ratio of 5:1 (figure 2, hatched columns) and 100 ng/mL IL-10, hyphal damage was compared with 10.8% ‫ע‬ 6.2% for controls ( ). At the same concentra-37.9% ‫ע‬ 6.6% P ϭ .006 tion and at an E:T ratio of 2:1 (open columns), hyphal damage was compared with for controls 5.8% ‫ע‬ 4.2%
26.8% ‫ע‬ 6.4% ( ). P ϭ .002
Effect of IL-10 on bactericidal activity of MNC against S. aureus. The effect of IL-10 on bactericidal activity of MNC against S. aureus (percent killing) was evaluated by use of a cfu assay at an E:T ratio of 1:1. After incubation of MNC with 20 ng/mL IL-10 at 37ЊC for 2-3 days, the capacity of IL-10-pretreated MNC to kill bacteria in the presence of serum was significantly decreased compared with control MNC. Percent killing was compared with 6.5% ‫ע‬ 10.0% 32.7% ‫ע‬ 9.4% for controls, (figure 3). In two experiments using 2 P ϭ .046 ng/mL, no difference from untreated controls was found, and no further decrease at 100 ng/mL was observed (data not shown).
Effect of IL-10 on phagocytosis of opsonized and unopsonized blastoconidia of C. albicans. To evaluate the phagocytic activity of IL-10-treated MNC against serum-opsonized blastoconidia of C. albicans, glass coverslip-adherent MNC were incubated with 0, 2, 20, and 100 ng/mL IL-10 for 2-3 days. In these experiments, the MNC-induced percent phagocytosis of blastoconidia was not altered by 2 or 20 ng/mL IL-10. However, there was a small but significant increase after incubation of MNC with 100 ng/mL IL-10 at 37ЊC to com-68.5% ‫ע‬ 3.4% pared with of controls (figure 4, ). The 60.4% ‫ע‬ 3.1% P ! .01 increase was modest but consistent in all donors. The phagocytic index was not significantly altered by IL-10 treatment at any concentration used. For example, at 100 ng/mL of IL-10, the phagocytic index was versus for 1.82 ‫ע‬ 0. 16 1.73 ‫ע‬ 0.11 controls (
). P 1 .1 Since C. albicans blastoconidia, unlike bacteria, may also be phagocytosed by monocytes and macrophages through serumindependent mechanisms utilizing mannose ligands [37] , the effect of IL-10 on phagocytosis of unopsonized C. albicans blastoconidia was evaluated. Again, glass coverslip-adherent MNC were incubated with 0, 2, 20, and 100 ng/mL IL-10 at 37ЊC for 2-3 days. In these experiments, MNC-induced baseline (0 ng/mL) percent phagocytosis of blastoconidia was , significantly lower than that of serum-opsonized 38.0% ‫ע‬ 5.8% blastoconidia (
). This percent phagocytosis was not P ϭ .007 altered after incubation of MNC with 2, 20, or even 100 ng/ mL IL-10. Similarly, the phagocytic index was , 1.46 ‫ע‬ 0.1 which was not quite significantly lower than that of serumopsonized blastoconidia ( ). Again, this was not altered P ϭ .088 by IL-10 treatment at any concentration used.
Effect of IL-10 on phagocytosis of opsonized S. aureus. The phagocytic activity of IL-10-treated MNC against opsonized S. aureus also was evaluated. To this end, MNC were incubated with 0, 2, 20, and 100 ng/mL IL-10 for 2-3 days. In these experiments, the MNC-induced percent phagocytosis of bacteria was and was not altered significantly by 83.0% ‫ע‬ 5.1% incubation of MNC with 2, 20, or 100 ng/mL (at 100 ng/mL, the percent phagocytosis was ; data from 5-8 79.4% ‫ע‬ 4.7% experiments). Similarly, the weighted phagocytic index was and was not significantly altered by IL-10 treatment. 2.9 ‫ע‬ 0.1
Effect of IL-10 on superoxide production by MNC. IL-10-pretreated MNC exhibit suppressed O 2Ϫ production in response to PMA and FMLP [36] . In the present study, we confirmed these findings with both stimuli used as controls. Concentrations of IL-10 within the range of 2-20 ng/mL were found to be the most significantly effective in suppressing O 2Ϫ production in response to these two stimuli. For example, with 20 ng/mL IL-10, O 2Ϫ production in response to PMA was 3.3 ‫ע‬ 0.2 nmol O 2Ϫ per 10 6 MNC per 15 min versus for 5.0 ‫ע‬ 0.5 control (34% decrease, ) and in response to FMLP was P ϭ .019 versus nmol for control (30% decrease, 1.9 ‫ע‬ 0.3 2.7 ‫ע‬ 0.2 ). However, pretreatment of MNC with IL-10 was not P ϭ .04 shown to significantly alter O 2Ϫ production in response to opsonized C. albicans blastoconidia. Thus, baseline O 2Ϫ production was nmol versus nmol produced 1.2 ‫ע‬ 0.2 1.5 ‫ע‬ 0.3 after treatment with 20 ng/mL IL-10 (results from 10 or 11 experiments).
Discussion
In this study, IL-10 was found to suppress the antifungal activity of MNC against blastoconidia and hyphae of C. albicans and antibacterial activity against S. aureus followed by a similar decrease of oxidative burst in response to soluble stimuli. In contrast, a high concentration of IL-10 exhibited a small albeit consistent increase of MNC phagocytic activity against serum-opsonized C. albicans but did not alter phagocytosis of S. aureus and O 2Ϫ production in response to blastoconidia. These effects were achieved by IL-10 concentrations within 2 and 100 ng/mL that can be easily achieved or even exceeded by exogenous administration of 10-25 mg/kg [24] or by endogenous secretion of IL-10 in response to endotoxin during septic shock [33, 34] .
Our study constitutes the first comprehensive report on the role of IL-10 on phagocytic host defenses against common bacterial and fungal pathogens of humans in vitro. That IL-10 mediates suppression of human monocyte effector functions such as conidiocidal activity and hyphal damage, as well as bactericidal activity, is consistent with previous findings of IL-10 effects on different immune functions [10-16, 18, 20, 21, 23, 38-41] . Recently, IL-10 has been reported to exert a deleterious effect on the outcome of established murine candidiasis, and this effect correlated with inhibition of nitric oxide-mediated candidacidal activity of macrophages [23] . As human mononuclear phagocytes do not generate sufficient nitric oxide for antimicrobial activity [42, 43] , there was a critical need to investigate the effect of IL-10 on human MNC against C. albicans. Our findings correlate with the above effect [23] .
These results are also consistent with and may serve as an explanatory basis for recent in vivo findings in pneumonia due to K. pneumoniae [26] and S. pneumoniae [27] as well as disseminated C. albicans infection [28] . Whereas IL-10 has an attenuating effect on septic shock [44, 45] , its neutralization appears to decrease bacterial cfu counts and improve outcome of infected animals [26] [27] [28] . It appears that IL-10, like many other naturally occurring biologicals, is a two-sided sword and that, although IL-10 is very useful by attenuating excessive inflammatory reaction [44] [45] [46] [47] , it has also adverse inhibitory effects on antimicrobial functions of mononuclear phagocytes. Whether IL-10 has similar inhibitory effects on neutrophil effector functions is less well established [48] .
The increased phagocytic activity of MNC against serumopsonized blastoconidia of C. albicans found in this study is similar to the increased phagocytic activity of MNC against conidia of Aspergillus fumigatus found previously [36] . These increases are expected in the light of recent findings that IL-10 stimulates MNC FcgR surface expression and cytotoxic activity, which may imply a distinct regulation of phagocytosis and antibody-dependent cellular cytotoxicity [49] . Moreover, while our studies were in progress, Capsoni et al. [50] reported that the IL-10-induced receptor up-regulation, restricted to FcgRI expression, is correlated with augmentation of phagocytosis of erythrocytes and Saccharomyces cerevisiae. Taken together, these observations suggest that IL-10 is not only a macrophage "deactivating" cytokine [14] but that it has more diverse effects on macrophages regulating their functions. In contrast, phagocytosis of unopsonized blastoconidia, presumably occurring through contribution of mannose receptors, at least in part, was not affected by IL-10 treatment. This finding differs from the ability of IL-4, a similar "monocyte deactivating" cytokine [51] , to enhance phagocytosis of unopsonized blastoconidia [52] .
IL-10 was found to significantly decrease the percent killing of blastoconidia by MNC. This effect was partially neutralized by anti-IL-10 antibodies produced in the supernatant of a hybridoma cell line culture. The same supernatant containing the anti-IL-10 antibodies was utilized in a previous study, in which we demonstrated that anti-IL-10 inhibited superoxide anion production by MNC in response to FMLP [36] . The partial effect of neutralization of the IL-10 effect may have been due to low concentration or activity of antibody in the supernatant or non-IL-10 suppressive elements in the supernatant of the hybridoma cell line culture. The cell culture was endotoxin-free, and there was no contamination with endotoxin during preparation of supernatant. However, these contaminating materials are usually stimulatory for MNC function and not suppressive.
The immunomodulatory effects of IL-10 on phagocytic cells may vary with function and target organism. In this study, while not affecting phagocytosis of S. aureus, IL-10 inhibited bactericidal activity against this organism. Similarly, IL-10 did not affect phagocytosis of Legionella pneumophila, but it suppressed its intracellular killing by human monocytes and alveolar macrophages [53] . By comparison, IL-10 has been recently reported not to affect intracellular growth of Mycobacterium avium in human monocytes [54] .
The IL-10-mediated increase of phagocytic activity of MNC against serum-opsonized blastoconidia at a high concentration is associated with suppressed fungicidal activity and may be consistent with the Th2-type suppressive properties of IL-10. Since killing of blastoconidia predominantly takes place intracellularly, the enhancing effect of IL-10 on phagocytosis appears to be responsible for the only modest suppression (∼50%) of conidiocidal activity. Intracellular killing, however, is probably overwhelmingly more important in the microbial clearance than phagocytosis and, thus, the overall in vivo effect of IL-10 is one of suppression. Along a similar line of investigation, IFN-g, despite being one of the most potent activators of monocyte antimicrobial activity, reduced ingestion of erythrocytes and S. cerevisiae [50] .
If phagocytosis of C. albicans blastoconidia is augmented but followed by suppressed conidiocidal activity, as observed in the present study, then the intracellular fungal burden is increased, providing a sanctuary for phagocytosed intracellular C. albicans blastoconidia, and thus perpetuation of chronic infection. As the excessive viable intracellular blastoconidia overwhelm the suppressed capacity of MNC to kill them and grow, MNC are unable to stop the infection. Further, the IL-10-mediated suppression of extracellular hyphal damage permits more growth of hyphae and a net increase of invasive fungal elements.
Chronic disseminated candidiasis [55] is a refractory fungal infection in patients with cancer; the pathogenesis of this mycosis may involve IL-10 or other Th2-type cytokines. Becoming clinically overt upon recovery from neutropenia, this mycosis has long been an immunologic enigma, with some patients continuing to demonstrate progressive infection despite having recovered from neutropenia. That IL-10 mediates increased phagocytosis and suppressed conidiocidal activity followed by increased susceptibility to disseminated candidiasis [23, 28] suggests that it may also contribute to the pathogenesis of this infection.
The mechanism of down-regulation of MNC antifungal and antibacterial activities is unclear. IL-10 has been previously found to have opposing effects to IFN-g [22, 23] . In addition, IL-10 dramatically decreases production of TNF-a [20] , a potent up-regulator of antimicrobial function of phagocytes [56] . The suppression of antifungal activity against blastoconidia, hyphae, and bacteria may be associated with down-regulation of such "immunoenhancing" cytokines at transcriptional and posttranscriptional levels. Similar effects of IL-10 on secretion of proinflammatory monokines TNF-a and IL-1b in response to C. albicans have been recently published [9] . Whereas our study addresses the effects of IL-10 on innate phagocytic response, IL-10 also modulates antibody responses, which occupy key roles in host defense against fungi and bacteria [57] .
IL-10 may be produced at increased levels during the course of human immunodeficiency virus infection and correlate with Th cell dysfunction in these patients [58] . In addition, it has been shown that alterations in Th functional phenotype with decreased Th1-type cytokine levels are associated with macrophage dysfunction [59] . Of note, these antifungal defects were reversible by IFN-g. Thus, the Th2 milieu may predispose human immunodeficiency virus-infected patients to develop chronic bacterial or fungal infections.
These effects of IL-10 on phagocytic host defenses may be particularly important in immunopathogenesis and management of respective infections (i.e., by blocking suppressive effects of endogenous IL-10) and in patients receiving IL-10 as an antiinflammatory cytokine. As IL-10 is being developed as a novel antiinflammatory cytokine [24, 25] , our findings and those of others suggest that there may also be an increased risk for opportunistic bacterial and fungal infections. IL-10 may impair clearance of organisms during IL-10 antiinflammatory therapy. One potential approach that has been proposed is to simultaneously administer antibacterial and/or antifungal agents to control the infectious organism while IL-10 attenuates the detrimental inflammatory process [9, 46] .
